Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02069769 · ClinicalTrials.gov registry record · NA
Ensuring Communication in Hospice by Oncology Study (ECHO)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02069769: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02069769 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02069769, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to determine if scheduled communication with the oncology team through phone calls is helpful to caregivers with the transition to hospice care.
Interventions
- BEHAVIORAL communication with oncology team
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02069769
The ClinicalTrials.gov registry entry for NCT02069769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which communication with oncology team is the first listed.
NCT02069769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02069769 about?
NCT02069769 is a clinical study titled "Ensuring Communication in Hospice by Oncology Study (ECHO)". The goal of this study is to determine if scheduled communication with the oncology team through phone calls is helpful to caregivers with the transition to hospice care.
What is the current status of trial NCT02069769?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-01. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02069769?
The interventions under investigation include: communication with oncology team (BEHAVIORAL).
Who is sponsoring clinical trial NCT02069769?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.